Cellectis SA
D

CLLS

0.96100
USD
0.00
(0.31%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
106
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
96,804,203
أصول ذات صلة

العنوان: Cellectis SA

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.